- Home
- CFLT vs RVMD Comparison
CFLT vs RVMD Comparison
Compare CFLT & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFLT
- RVMD
- Stock Information
- Founded
- CFLT 2014
- RVMD 2014
- Country
- CFLT United States
- RVMD United States
- Employees
- CFLT N/A
- RVMD N/A
- Industry
- CFLT EDP Services
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CFLT Technology
- RVMD Health Care
- Exchange
- CFLT Nasdaq
- RVMD Nasdaq
- Market Cap
- CFLT 8.5B
- RVMD 7.5B
- IPO Year
- CFLT 2021
- RVMD 2020
- Fundamental
- Price
- CFLT $26.40
- RVMD $37.02
- Analyst Decision
- CFLT Buy
- RVMD Strong Buy
- Analyst Count
- CFLT 31
- RVMD 12
- Target Price
- CFLT $31.19
- RVMD $69.50
- AVG Volume (30 Days)
- CFLT 5.5M
- RVMD 1.5M
- Earning Date
- CFLT 07-30-2025
- RVMD 08-11-2025
- Dividend Yield
- CFLT N/A
- RVMD N/A
- EPS Growth
- CFLT N/A
- RVMD N/A
- EPS
- CFLT N/A
- RVMD N/A
- Revenue
- CFLT $1,017,525,000.00
- RVMD N/A
- Revenue This Year
- CFLT $21.52
- RVMD N/A
- Revenue Next Year
- CFLT $18.36
- RVMD $234.26
- P/E Ratio
- CFLT N/A
- RVMD N/A
- Revenue Growth
- CFLT 24.11
- RVMD N/A
- 52 Week Low
- CFLT $17.79
- RVMD $29.17
- 52 Week High
- CFLT $37.90
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- CFLT 59.41
- RVMD 42.51
- Support Level
- CFLT $24.87
- RVMD $36.60
- Resistance Level
- CFLT $27.79
- RVMD $38.45
- Average True Range (ATR)
- CFLT 0.90
- RVMD 1.18
- MACD
- CFLT 0.10
- RVMD -0.06
- Stochastic Oscillator
- CFLT 65.08
- RVMD 13.74
About CFLT Confluent Inc.
Confluent Inc provides a data streaming platform that enables customers to connect their applications, systems, and data layers and can be deployed as a fully managed cloud-native software-as-a-service (SaaS) offering. Its products include Confluent Cloud, a self-managed software offering, Confluent Platform, a managed service offering where the raw data resides inside a customer's cloud environment, and WarpStream, among others. Confluent also offers professional services and education services. The company generates revenue from the sale of subscriptions and services. Geographically, it generates a majority of its revenue from its business in the United States and the rest from International markets.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.